| Active substance |
Budesonide |
| Also known as |
Budesonidum |
| Blood pressure |
Typically no effect on blood pressure |
| Chemical name |
(RS)-11ОІ,16О±,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde |
| Dosage (medical) |
Inhalation (100 to 800 micrograms per day), Oral (9 mg per day), Nasal spray (256 micrograms per day) |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces inflammation, suppresses immune response |
| Formula |
C25H34O6 |
| Half-life |
2 to 3.6 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not specific for standard drug tests |
| Main action |
Anti-inflammatory |
| Side effects |
Oral thrush, hoarseness, cough, headache, nausea, adrenal suppression |
| Storage conditions |
Store in a cool, dry place away from direct sunlight |
| Strength |
100mcg |
| Substance class |
Corticosteroid |
| Trade name |
Pulmicort, Rhinocort |
| Use in sports |
Not commonly used, except for legitimate asthma treatment |
| Water Retention |
Minimal |
| Manufacturer |
Cipla Ltd. |
| Packing |
1 Inhaler/pack |
